Ocrevus Subcutaneous Study for Safety and Tolerability
Research payments
$137,770
Through program year 2025, $137,770 in research payments was reported against Ocrevus Subcutaneous Study for Safety and Tolerability, across 20 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $137,770 | 20 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Bennett Myers Durham, NC Named on 2 payments
- Sherrill Loring Atlanta, GA Named on 2 payments
- Tamara Miller Fort Collins, CO Named on 2 payments
- Angel Chinea Guaynabo, PR Named on 2 payments
- Curtis Schreiber Rochester, MN Named on 1 payment
- Nida Laurin Scottsdale, AZ Named on 1 payment
- Aamr Herekar Cleveland, OH Named on 1 payment
- Lee Stein Memphis, TN Named on 1 payment
- Craig Herrman Indianapolis, IN Named on 1 payment
- Brian Barry Chevy Chase, MD Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.